What is ECB Equine?
ECB Equine stands as a preeminent manufacturer in the equine therapy industry, specializing in high-performance aqua treadmills, mobile spas, and advanced cryotherapy solutions. With a robust portfolio of over 400 units deployed globally, the company provides essential recovery and rehabilitation infrastructure for racehorses and elite competition animals. Their market position is defined by a commitment to engineering excellence and a deep understanding of equine physiology, ensuring that their therapeutic hardware remains the gold standard for veterinary clinics and professional training facilities worldwide.
How much funding has ECB Equine raised?
ECB Equine has raised a total of $18K across 1 funding round:
Debt
$18K
Debt (2021): $18K with participation from PPP
Key Investors in ECB Equine
PPP
Public-Private Partnership
What's next for ECB Equine?
With the current Series A/B growth stage funding, ECB Equine is poised to scale its manufacturing capabilities and enhance its research and development pipeline. The strategic deployment of this capital will likely focus on expanding international distribution channels and integrating next-generation sensor technology into their existing product line. As the demand for sophisticated animal wellness solutions continues to rise, ECB Equine is well-positioned to capitalize on these market trends, driving long-term value through innovation and sustained operational growth.
See full ECB Equine company page